Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitochondrial dysfunction--a pathogenetic factor in Parkinson's disease.

H Reichmann1, B Janetzky

  • 1Department of Neurology, Technical University of Dresden, Germany. heinz.reichmann@mailbox.tu-dresden.de

Journal of Neurology
|September 19, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increased risk of acute stroke among patients with severe COVID-19: a multicenter study and meta-analysis.

European journal of neurology·2020
Same author

[Dystonia Non-Motor Symptoms Questionnaire (DNMSQuest) for assessment of non-motor symptoms in dystonia : Intercultural adaptation in the German language].

Der Nervenarzt·2020
Same author

MMW Fortschritte der Medizin·2019
Same author

Perfusion computed tomography in posterior circulation stroke: predictors and prognostic implications of focal hypoperfusion.

European journal of neurology·2018
Same author

Rasagiline improves polysomnographic sleep parameters in patients with Parkinson's disease: a double-blind, baseline-controlled trial.

European journal of neurology·2018
Same author

Charcot Foot.

Der Orthopade·2017
Same journal

The dual role of mTOR in multiple sclerosis pathophysiology: a systematic review.

Journal of neurology·2026
Same journal

Brain-first versus body-first Parkinson's disease: Differential findings on pupillary, brainstem and vagus sonography.

Journal of neurology·2026
Same journal

Spontaneous intracranial hypotension due to pelvic cerebrospinal fluid leak.

Journal of neurology·2026
Same journal

Morbidity and medication use preceding a diagnosis of late-onset Alzheimer's disease: a Danish nationwide study.

Journal of neurology·2026
Same journal

Comorbid autoimmune disease in stiff-person syndrome spectrum disorder: a systematic review and meta-analysis.

Journal of neurology·2026
Same journal

Tetrahydrocannabinol/cannabidiol in the treatment of restless legs syndrome.

Journal of neurology·2026
See all related articles

Parkinson's disease may involve decreased respiratory chain complex I activity in specific brain cells. This enzyme defect, crucial for cell survival, is not reliably detected in blood cells, hindering diagnostic potential.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Genetics

Background:

  • The etiology of Parkinson's disease (PD) remains elusive.
  • Dopaminergic cell degeneration is a hallmark of PD.
  • Reduced activity of respiratory chain complex I is a proposed factor in this degeneration.

Purpose of the Study:

  • To investigate the role of respiratory chain complex I activity in Parkinson's disease pathogenesis.
  • To determine the tissue specificity of complex I defects in PD.
  • To evaluate the diagnostic utility of complex I activity measurements in peripheral cells.

Main Methods:

  • Analysis of respiratory chain complex I activity in affected brain regions (substantia nigra pars compacta).
  • Investigation of potential genetic (nuclear and mitochondrial genomes) and environmental (exo-/endotoxins) causes for complex I dysfunction.

Related Experiment Videos

  • Comparison of complex I activity in blood and muscle cells between PD patients and healthy controls.

    • Main Results:

    • Complex I enzyme abnormality is primarily observed in the substantia nigra pars compacta in PD.
    • No specific mitochondrial genome abnormality directly linked to complex I defect has been identified.
    • Age-related mitochondrial DNA deletions occur but do not fully explain the complex I defect.
    • Complex I activity measurements in blood cells show significant overlap between PD patients and controls, lacking diagnostic distinctiveness.

    Conclusions:

    • Decreased respiratory chain complex I activity in postmitotic cells, particularly in the substantia nigra, may be a critical factor in Parkinson's disease cell death.
    • Peripheral blood cell measurements of complex I activity are not sufficiently distinctive for diagnosing Parkinson's disease.
    • Further research is needed to elucidate the precise causes of complex I dysfunction in PD.